Comparison of in vitro activities of 11 antifungal agents against Trichophyton verrucosum isolates associated with a variety hosts and geographical origin

Dominik Łagowski,Sebastian Gnat,Aneta Nowakiewicz,Marcelina Osińska
DOI: https://doi.org/10.1111/myc.13042
2019-12-23
Mycoses
Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Background</h3><p>The high prevalence of dermatophytosis in animals is usually associated with extra expenditure on prevention, diagnosis, and long‐term treatment. Humans are usually infected from animals, also from asymptomatic carriers, through direct contact or indirectly via fungus‐bearing hair, scales, and fomites. Despite the medical importance of <i>Trichophyton verrucosum</i> infections, there are limited <i>in vitro</i> data on the fungal susceptibility to antifungal drugs, including new‐generation triazoles, imidazoles, and allyloamines. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Objectives</h3><p>The aim of the current study was to evaluate comprehensively the <i>in vitro</i> activity of 11 antifungal drugs against a large collection of <i>T. verrucosum</i> isolates obtained in Poland, Latvia, Lithuania, and Slovakia from humans and animals using a microdilution assay. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Methods</h3><p><i>In vitro</i> susceptibility testing of 11 antifungal drugs was performed according to the Clinical and Laboratory Standards Institute (CLSI) document M38. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>The MICs of clotrimazole, ciclopirox, enilconazole, miconazole, naftifine, and terbinafine against all <i>T. verrucosum</i> isolates were below 1 μg/ml, whereas those of fluconazole, griseofulvin, itraconazole, ketoconazole, and voriconazole were above 1 μg/ml. Ciclopirox was demonstrated to have superior activity against all strains in comparison with the other drugs, whereas fluconazole exerted the weakest <i>in vitro</i> effect and exhibited the highest MIC values. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusions</h3><p>Our study has shown that drugs of different chemical origin have satisfactory antifungal activity and can be promising candidates for the treatment of <i>T. verrucosum</i> dermatophytosis. Moreover, no significant disparity in drug sensitivity between isolates obtained from different hosts and geographical regions have been demonstrated. </p></section>
dermatology,mycology
What problem does this paper attempt to address?